Colorectal Cancer Clinical Trials Review, Q4 2010

• Publication date: November 2010

This report provides in-depth information and data relating to the clinical trials on Colorectal Cancer . It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining ...

This report provides in-depth information and data relating to the clinical trials on Colorectal Cancer . It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Colorectal Cancer .

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of market experts.

Scope of the Research

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade
- Number of clinical trials sector ed by key drugs
- Clinical trial overview of top 20 firms, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Firms, and so on.
- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute, and others

Why Should You Get This Report?

- Understand the clinical trial dynamics of a Colorectal Cancer
- Number of trials by zone and by country
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals/ Firms
- Prominent drug comparisions based on the number of trials

Pathology Industry in South America

1 Table of Contents
I. 1 List of Data tables
I. 2 List of Charts

II Introduction
II. 1 Report Guidance

III Colorectal Cancer Overview

IV Clinical Trials by Region
IV. 1 Clinical Trials by Country
IV. 1.1 Top 5 Countries Contributing to Clinical Trials in Asia-Pacific
IV. 1.2 Top 5 Countries Contributing to Clinical Trials in Europe
IV. 1.3 Top Countries Contributing to Clinical Trials in North America
IV. 1.4 Top Countries Contributing to Clinical Trials in Central and South America
IV. 2 Clinical Trials by BRIC Countries

V Clinical Trials by Phase
V. 1 In Progress Trials by Phase

VI Clinical Trials by Trial Status
VI. 1 Clinical Trial Success Rate
VI. 2 Unaccomplished Trials of Colorectal Cancer

VII Subjects Recruited Over a period
VII. 1 Enrollment Trends by Phase for the Last December ade
8 Key Sponsors
VIII. 1 Top 10 Firms Participating in Colorectal Cancer Clinical Trials

IX Prominent Drug Comparisons

X Clinical Trial Profiles
X. 1 Clinical Trial conducted by Top Firms
X. 2 Clinical Trial Data by Top Universities / Institutes / Hospitals

XI Appendix
XI. 1 Abbreviations
XI. 2 Definitions
XI. 3 Research Methodology
XI. 4 Secondary Research
XI. 5 GlobalData Consulting
XI. 6 Contact Us
XI. 7 Disclaimer

XII Source

1.1 List of Data tables
Data table 1: Colorectal Cancer Clinical Trials by Region
Data table 2: Colorectal Cancer Clinical Trials by Key Countries
Data table 3: Top Five Countries Contributing for Colorectal Cancer Clinical Trials in Asia-Pacific
Data table 4: Top Five Nations Contributing to Colorectal Cancer Clinical Trials in Europe
Data table 5: Top Nations Contributing to Colorectal Cancer Clinical Trials in North America
Data table 6: Top Nations Contributing to Colorectal Cancer Clinical Trials in Central and South America
Data table 7: Colorectal Cancer Clinical Trials by BRIC Nations
Data table 8: Colorectal Cancer Clinical Trials by Phase
Data table 9: Colorectal Cancer Clinical Trials in Progress by Phase
Data table 10: Colorectal Cancer Clinical Trials by Trial Status
Data table 11: Colorectal Cancer Clinical Trial Success Rate, from 2005 to 2010
Data table 12: Suspended Clinical Trials for Colorectal Cancer
Data table 13: Terminated Clinical Trials for Colorectal Cancer
Data table 14: Withdrawn Clinical Trials for Colorectal Cancer
Data table 15: Enrollment Target Trends by Phase and Year, Colorectal Cancer Clinical Trials, from 2001 to 2010
Data table 16: March ket Players, Colorectal Cancer Clinical Trials, 2010
Data table 17: Colorectal Cancer Clinical Trials, Top 10 Firms by Phase
Data table 18: Colorectal Cancer Clinical Trials by Prominent Drugs
Data table 19: Clinical Trial conducted by Top Firms
Data table 20: Clinical Trial Data by Top Universities / Institutes / Hospitals

1.2 List of Charts
Chart 1: Colorectal Cancers Clinical Trials by Region
Chart 2: Colorectal Cancers Clinical Trials by Key Countries
Chart 3: Colorectal Cancers Clinical Trials In Progress by Key Countries
Chart 4: Top Five Countries Contributing to Breast Cancer Clinical Trials in Asia-Pacific
Chart 5: Top Five Nations Contributing to Breast Cancer Clinical Trials in Europe
Chart 6: Top Nations Contributing to Breast Cancer Clinical Trials in North America
Chart 7: Top Nations Contributing to Breast Cancer Clinical Trials in Central and South America
Chart 8: Colorectal Cancers Clinical Trials by BRIC Nations
Chart 9: Colorectal Cancers Clinical Trials by Phase
Chart 10: Colorectal Cancers Clinical Trials in Progress by Phase
Chart 11: Colorectal Cancers Clinical Trials by Trial Status
Chart 12: Colorectal Cancers Clinical Trial Success Rate, from 2005 to 2010
Chart 13: Average Enrollment Target Trends, Breast Cancer Clinical Trials, from 2005 to 2010
Chart 14: Enrollment Target Trends by Phase and Year, Breast Cancer Clinical Trials, from 2001 to 2010
Chart 15: March ket Players, Breast Cancer Clinical Trials, 2010
Chart 16: Colorectal Cancers Clinical Trials, Top 10 Firms by Phase
Chart 17: Colorectal Cancers Clinical Trials by Prominent Drugs

Companies mentioned